11 – 17 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2014
-
Mark
A Catalyst for Change: The European Cancer Patient's Bill of Rights.
2014) In The Oncologist(
- Contribution to journal › Article
- 2013
-
Mark
Målriktad behandling av bröstcancer
2013)(
- Other contribution › Miscellaneous
-
Mark
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel
(
- Contribution to journal › Article
- 2006
-
Mark
Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.
(
- Contribution to journal › Article
-
Mark
Basoluminal carcinoma: A new biologically and prognostically distinct entity between basal and luminal breast cancer
(
- Contribution to journal › Article
- 2000
-
Mark
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : a randomised trial
(
- Contribution to journal › Article
- 1994
-
Mark
Metabolism of estrone sulfate by normal breast tissue : Influence of menopausal status and oral contraceptives
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »